This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LAKE SUCCESS, N.Y., Jan. 24, 2011 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that Guillaume Saint - Clair has been named to head the Company's international pharmaceutical intermediates business.
Mr. Saint - Clair joined Aceto in 2001 as a result of the Company's acquisition of Schweizerhall, and has held various management positions, most recently being responsible for managing Aceto's European pharmaceutical intermediates and specialty chemicals businesses since January 2010. Mr. Saint - Clair holds a Masters of Physical Organic Chemistry from the University Jean Fourrier in Grenoble.
Commenting on the announcement, Vincent G. Miata, President of Aceto, said, "Guillaume brings many years of experience to this position having a long standing knowledge of the products, customers and suppliers. This new assignment as International Vice President, Pharmaceutical Intermediates, is an expansion of his current responsibilities and I look to Guillaume to bring his demonstrated skills to manage our global pharmaceutical intermediates business. I am confident that he will be as successful as he has been in his past roles at Aceto."
Aceto Corporation, incorporated in 1947, is a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products. With a physical presence in ten countries, Aceto distributes over 1,000 chemicals and pharmaceuticals used principally as raw materials in the pharmaceutical, crop protection, surface coating/ink and general chemical consuming industries. Aceto's global operations, including a staff of 26 in Shanghai and 14 in India, are unique in the industry and enable its worldwide sourcing and regulatory capabilities. (ACET-F)
CONTACT: Theodore Ayvas
Director of Corporate Communications
& Investor Relations